EA201391790A1 - Очистка prame - Google Patents

Очистка prame

Info

Publication number
EA201391790A1
EA201391790A1 EA201391790A EA201391790A EA201391790A1 EA 201391790 A1 EA201391790 A1 EA 201391790A1 EA 201391790 A EA201391790 A EA 201391790A EA 201391790 A EA201391790 A EA 201391790A EA 201391790 A1 EA201391790 A1 EA 201391790A1
Authority
EA
Eurasian Patent Office
Prior art keywords
diluent
prame
clean
replacing
relates
Prior art date
Application number
EA201391790A
Other languages
English (en)
Inventor
Оливье С. Жермай
Стефан Андре Жодар
Пол Ги Арвенг
Амина Лаанан
Оливье Патрик Ле Бюсси
Доминик Ингрид Лемуан
Леонар Доде
Original Assignee
Глаксосмитклайн Байолоджикалс С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1112658.8A external-priority patent/GB201112658D0/en
Priority claimed from GBGB1115737.7A external-priority patent/GB201115737D0/en
Application filed by Глаксосмитклайн Байолоджикалс С.А. filed Critical Глаксосмитклайн Байолоджикалс С.А.
Publication of EA201391790A1 publication Critical patent/EA201391790A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001189—PRAME
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Abstract

Настоящее изобретение относится к способам очистки PRAME. В частности, настоящее изобретение относится к способу снижения агрегации PRAME при замене разбавителя А на разбавитель В, включающему: (1) добавление полианионного соединения к разбавителю А до или одновременно с заменой и (2) перенос белка из разбавителя А в разбавитель В. Также предложены композиции, приготовленные посредством этого способа.
EA201391790A 2011-07-22 2012-07-20 Очистка prame EA201391790A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1112658.8A GB201112658D0 (en) 2011-07-22 2011-07-22 Prame purification
GBGB1115737.7A GB201115737D0 (en) 2011-09-12 2011-09-12 Prame purification
PCT/EP2012/064340 WO2013014105A1 (en) 2011-07-22 2012-07-20 Prame purification

Publications (1)

Publication Number Publication Date
EA201391790A1 true EA201391790A1 (ru) 2014-06-30

Family

ID=46551555

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201391790A EA201391790A1 (ru) 2011-07-22 2012-07-20 Очистка prame

Country Status (12)

Country Link
US (1) US20140234424A1 (ru)
EP (1) EP2734539A1 (ru)
JP (1) JP2014529338A (ru)
KR (1) KR20140049569A (ru)
CN (1) CN103717613A (ru)
AU (1) AU2012288926A1 (ru)
BR (1) BR112014001052A2 (ru)
CA (1) CA2841380A1 (ru)
EA (1) EA201391790A1 (ru)
MX (1) MX2014000893A (ru)
WO (1) WO2013014105A1 (ru)
ZA (1) ZA201400061B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
BR112020011443A2 (pt) * 2017-12-13 2020-12-01 Inovio Pharmaceuticals, Inc. molécula de ácido nucleico e seu uso, vetor e seu uso, composição, proteína e vacina
CN113278064B (zh) * 2021-07-20 2021-11-02 山东信得科技股份有限公司 一种用于胚毒类抗原净化处理的方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE466259B (sv) 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
EP0468520A3 (en) 1990-07-27 1992-07-01 Mitsui Toatsu Chemicals, Inc. Immunostimulatory remedies containing palindromic dna sequences
US5830753A (en) 1994-09-30 1998-11-03 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
GB0411411D0 (en) * 2004-05-21 2004-06-23 Glaxosmithkline Biolog Sa Vaccines
TWI434697B (zh) 2007-01-15 2014-04-21 Glaxosmithkline Biolog Sa 疫苗
CA2687632C (en) * 2007-05-24 2013-01-15 Glaxosmithkline Biologicals S.A. Lyophilised antigen composition
GB0910045D0 (en) * 2009-06-10 2009-07-22 Glaxosmithkline Biolog Sa Novel compositions

Also Published As

Publication number Publication date
WO2013014105A1 (en) 2013-01-31
KR20140049569A (ko) 2014-04-25
EP2734539A1 (en) 2014-05-28
MX2014000893A (es) 2014-05-30
BR112014001052A2 (pt) 2017-02-21
US20140234424A1 (en) 2014-08-21
AU2012288926A1 (en) 2014-01-16
CA2841380A1 (en) 2013-01-31
CN103717613A (zh) 2014-04-09
ZA201400061B (en) 2017-08-30
JP2014529338A (ja) 2014-11-06

Similar Documents

Publication Publication Date Title
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
MY195289A (en) Anti IL-36R Antibodies
UY34559A (es) Inhibidores de bromodominios
DK2970283T3 (da) Substituerede 2-aza-bicyclo[2.2.1]heptan-3-carboxylsyre-(benzyl-cyano-methyl)-amider som inhibitorer af cathepsin-c
UY34515A (es) Triazolopiridinas sustituidas
EP3053931A3 (en) Chromatography matrices including novel staphylococcus aureus protein a based ligands
ECSP13013094A (es) Composiciones de limpieza de sal colina
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
EA201590887A1 (ru) Композиция
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
EA201391389A1 (ru) Кристаллы антител против склеростина и составы на их основе
ECSP13013093A (es) Composiciones líquidas de limpieza de sal
EA201490846A1 (ru) Новые производные арилхинолина
EA201070853A1 (ru) Кристаллический (r)-2-(4-циклопропансульфонилфенил)-n-пиразин-2-ил-3-(тетрагидропиран-4-ил)пропионамид
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
MX2014004074A (es) Metodo de tratamiento de condiciones del higado utilizando antagonistas de notch2.
BR112013030554A2 (pt) forma cristalina de ciclosporina a, métodos de preparação e métodos para uso da mesma
UY34329A (es) Compuestos de triazolopiridina
EA201400058A1 (ru) Соединения и композиции на основе амидопиридиловых эфиров и их применение против паразитов
EA201491978A1 (ru) Резиновые композиции
UY34553A (es) Procedimiento de preparación de la sal de l-arginina de perindoprilo
WO2012136909A3 (fr) HYDROGELS THIXOTROPES À BASE α-LACTALBUMINE, LEUR PROCÉDÉ DE PRÉPARATION ET LEURS UTILISATIONS